Diagnosis and treatment of Graves' disease
Abstract
Graves' disease (Basedow's goiter, exophtalmic goiter) is a systemic autoimmune disease resulting from the production of stimulating antibodies to the thyroid stimulating hormone (TSH) receptor; it is clinically manifested in lesions of the thyroid gland (TG) and thyrotoxicosis syndrome combined with extrathyroidal pathology (endocrine ophthalmopathy, pretibial myxedema, acropathy).
Keywords
болезнь Грейвса,
зоб,
тахикардия,
экзофтальм,
тиреотоксикоз,
тиамазол,
Graves' disease,
goiter,
tachycardia,
exophthalmos,
hyperthyroidism,
tiamazol
About the Author
V. V. Fadeyev
Head of the Department of Endocrinology, First Moscow State Medical University named after I.M.Sechenov
Russian Federation
References
1. Дедов И.И., Мельниченко ГА., Фадеев В.В. Эндокринология. М.: ГЭОТАР, 2007.
2. Barbesino G, Tomer Y. Clinical utility of TSH receptor antibodies. J. Clin. Endocrinol. Metab., 2013 Jun, 98(6): 2247-55.
3. Bartalena L. Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol., 2013 Dec, 9(12): 724-34.
For citations:
Fadeyev VV.
Diagnosis and treatment of Graves' disease. Meditsinskiy sovet = Medical Council. 2014;(4):44-49.
(In Russ.)
Views:
963